XGXingjie Guo

Xingjie Guo

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Xingjie Guo has a total of 123 co-authors. Here are the top co-authors by number of shared publications:

  • Jia Yu

    School of Pharmacy Shenyang Pharmaceutical University Shenyang China

    17 shared publications
  • Jia Yu

    Department Pharmaceutical Analysis, Institution Shenyang Pharmaceutical University, Shenyang, Liaoning Province, P.R. China

    14 shared publications
  • Zhen Jiang

    Department School of Pharmacy, Institution Shenyang Pharmaceutical University, Shenyang, China

    12 shared publications
  • Zhaokun Wang

    School of Pharmacy, Shenyang Pharmaceutical University, Shenyang, Liaoning, 110016, PR China

    10 shared publications
  • Pengfei Zhao

    Department School of Pharmacy, Institution Shenyang Pharmaceutical University, Shenyang, China

    9 shared publications
  • Shuang Li

    School of Pharmacy Shenyang Pharmaceutical University Shenyang Liaoning Province P. R. China

    9 shared publications

Latest Publications

  • Chiral separation and molecular simulation study of six antihistamine agents on a coated cellulose tri‐(3,5‐dimethylphenycarbamate) column (Chiralcel OD‐RH) and its recognition mechanisms

    by Yanru Liu, Xia Wang, Jia Yu, Xingjie Guo

    Enantiomeric separation of six antihistamine agents was first systematically investigated on a cellulose‐based chiral stationary phase (CSP), that is, cellulose tris‐(3,5‐dimethyl phenyl carbamate) (Chiralcel OD‐RH), under the reversed‐phase mode. Orphenadrine, meclizine, terfenadine, dioxopromethazine, and carbinoxamine enantiomers were completely separated under the optimized mobile phase conditions with resolutions of 5.02, 1.93, 1.68, 1.67, and 1.54, respectively. Mequitazine was partially separated with a resolution of 0.77. The influences of type and concentration of buffer salt, the pH of buffer solution, and the type and ratio of organic modifier on the chiral separation were evaluated and optimized. For a better insight into the enantiorecognition mechanisms, molecular docking was carried out via the Autodock software. The lowest binding energy and the optimal conformations of the analytes/CSP complexes were supplied, and the mechanisms of chiral recognition were determined. According to the results, the key interactions for the chiral recognition of these six analytes on CDMPC were π–π interactions, hydrophobic interactions, hydrogen bond interactions, and some special interactions.


  • Enantioseparation and determination of orphenadrine in rat plasma and its application to a stereoselective pharmacokinetic study

    by Yanru Liu, Yushan Ding, Yongbo Song, Xingjie Guo

    A simple, sensitive, and enantioselective HPLC-MS/MS method has been developed for the determination of orphenadrine (ORP) enantiomers in rat plasma for the first time. The method used diphenhydramine as the internal standard (IS), and plasma samples were extracted by liquid–liquid extraction with satisfactory recovery. Chiral separation of the ORP enantiomers was obtained on a Chiralcel OD-RH column (150 mm × 4.6 mm, 5 μm). The mobile phase consists of acetonitrile–ammonium bicarbonate buffer (30 mM, pH 9.0) (80 : 20, v/v). Sufficient resolution (Rs = 3.562) was achieved in a short analysis time (7 min). The multiple reaction monitoring (MRM) mode was used for the detection of ORP enantiomers and IS. The transitions of m/z 270.0 → 181.1 and 256.2 → 167.1 were chosen for monitoring the ORP enantiomers and IS, respectively. Linearity was confirmed in the range of 0.1–50.0 ng mL−1 with the lower limit of quantification of 0.1 ng mL−1 for both ORP enantiomers in plasma. After validation, the method was applied to the enantioselective pharmacokinetic study of ORP enantiomers in rat plasma following oral administration of 10 mg kg−1 racemic ORP. Significant differences (P < 0.05) of ORP enantiomers were observed in pharmacokinetic parameters including Cmax, AUC, t1/2, CL, Vd, MRT, and VRT, which indicated that enantioselective pharmacokinetic behavior of ORP enantiomers was present in rats.


  • Solid phase extraction procedure coupled with the chiral LC-ESI-MS/MS method for the enantioseparation and determination of butoconazole enantiomers in rat plasma and tissues: application to the enantioselective study on pharmacokinetics and tissue distribution

    by Siman Ma, Lina Wang, Guoxian Guo, Jia Yu, Xingjie Guo

    In the present study, a highly rapid, sensitive and enantioselective method was developed and fully validated for the separation and determination of butoconazole enantiomers in rat plasma and tissues by liquid chromatography–electrospray ionization coupled with tandem mass spectrometry (LC-ESI-MS/MS). The analytes and internal standard (tioconazole) were both extracted from plasma and tissue samples by the solid phase extraction (SPE) procedure with C18 cartridges. Satisfactory enantioseparation was achieved on a Chiralpak IC column by using acetonitrile/10 mM aqueous ammonium acetate (90 : 10, v/v) as a mobile phase. Butoconazole enantiomers and IS were detected in the multiple reaction monitoring (MRM) mode with a positive electrospray ionization source. A comprehensive validation of this method was conducted over the concentration range of 0.5–250 ng mL−1, and good linearity was obtained for each enantiomer with correlation coefficient (R2) greater than 0.991. The mean extraction recoveries were higher than 90.4%, and the relative error was well within the admissible range of −8.0 to 9.1% and the relative standard deviation was less than 11.5%. All the validation data demonstrated that the desirable specificity, carry-over, linearity, sensitivity, accuracy, precision, extraction recovery, matrix effect and stability were attained from the proposed approach. After validation, the established method was successfully applied to the study on stereoselective pharmacokinetics and tissue distribution in female Sprague-Dawley rats after transdermal administration of 10 mg kg−1 2% rac-butoconazole nitrate cream. It should be noted that this is the first report regarding the stereospecific study of butoconazole enantiomers in vivo.


  • Enantiomeric separation and molecular docking study of seven imidazole antifungal drugs on a cellulose tris-(3,5-dimethylphenylcarbamate) chiral stationary phase

    by Yanru Liu, Liangzhao Cai, Jia Lun, Min Zhao, Xingjie Guo

    The enantiomeric separation of seven imidazole antifungals was first systematically examined on a derivative polysaccharide chiral stationary phase (CSP), i.e. Chiralcel OD-RH in the reversed phase mode. The influence of the type and content of the organic modifier, the pH of buffer solution, type and concentration of buffer salt, and column temperature on enantiomeric separation were evaluated and optimized. The maximum resolution values for flutrimazole, econazole, miconazole, butoconazole, isoconazole, sulconazole, and climbazole were 2.36, 1.55, 0.89, 1.51, 0.96, 1.13, and 2.30. For a better understanding of the chiral recognition mechanism, detailed computational simulations of Chiralcel OD-RH interaction with seven pairs of enantiomers were carried out using the molecular docking software AutoDock. The various interactions affecting enantiomeric separation were confirmed in detail from the the molecular level. The modeling data were in agreement with the chromatographic results concerning enantioselectivity. It was found that the enantiomeric separation of imidazole analytes on Chiralcel OD-RH was the result of a mixture of hydrogen bonds, π–π, hydrophobic, dipole–dipole, and some special interactions. The docking results showed good agreement with our experimental results.


  • Enantioseparation and molecular modeling study of eight psychoactive drugs on a coated polysaccharide‐based chiral stationary phase

    by Liangzhao Cai, Mengyao Xue, Jia Lun, Shuang Li, Jia Yu, Xingjie Guo

    The enantioseparation of eight psychoactive drugs has been firstly performed on a coated cellulose‐based chiral stationary phase (Chiralcel OJ‐H). To obtain optimum separation conditions, the influences of alcohol modifiers and basic/acidic additives have been studied. As a result, except for the partial separation of oxybutynin enantiomers, the other seven drug enantiomers, including mirtazapine, sulpiride, promethazine, citalopram, oxazepam, donepezil, and cyamemazine, have been completely separated. Additionally, for gaining a better insight into the chiral recognition mechanisms, molecular docking was carried out using the Autodock software. Herein, binding energy and conformations of the chiral stationary phase complexes were provided, and it was found that the distinction in enantiomeric conformation determined the number and strength of intermolecular interactions between analytes and chiral stationary phase which resulted in the difference in binding energies of two enantiomers, and ultimately led to the different migration. These modeling results were in accordance with the observed enantioseparation results in high performance liquid chromatography experiments. At last, chiral separation mechanisms have been discussed in detail, and it has been confirmed that hydrogen bond, π–π, hydrophobic interactions, and some special interactions synergistically contributed to the enantioseparation of psychoactive drugs.


  • Open Access

    Enantioseparation and Determination of Penconazole in Rat Plasma by Chiral LC-MS/MS: Application to a Stereoselective Toxicokinetic Study

    by Siman Ma, Jia Lun, Yanru Liu, Zhen Jiang, Xingjie Guo

    In this study, a specific and sensitive method of liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS) was developed for the determination of penconazole enantiomers in rat plasma. The enantioseparation was achieved on a Chiralpak IC column by using acetonitrile/water (80:20, v/v) as the mobile phase. Penconazole enantiomers and internal standard l-lansoprazole (IS) were detected in multiple reaction monitoring (MRM) mode with positive electrospray ionization source. The method was validated over the concentration range of 2.5–250.0 ng mL−1 for penconazole enantiomers. Good linearity was obtained for both enantiomers with correlation coefficients (R) greater than 0.995. The relative error was well within the admissible range of −1.1–3.2%, and relative standard deviation was less than 6.0%. After validation, the established method was successfully applied to a stereoselective toxicokinetic study in female and male rats after oral administration of 50 mg kg−1 racemic penconazole. This is the first experiment regarding the stereospecific toxicokinetic study of penconazole and the bioanalytical approach for its quantitation in vivo.


  • Enantioselective LC‐MS/MS method for the determination of cloperastine enantiomers in rat plasma and its pharmacokinetic application

    by Jia Lun, Pengfei Zhao, Zhen Jiang, Yongbo Song, Xingjie Guo

    Cloperastine is a central antitussive used to reduce the frequency and intensity of coughing on a short‐term basis. In this study, a reliable chiral LC‐MS/MS technology has been developed for the quantification of cloperastine enantiomers in the rat plasma. Carbinoxamine was selected as the internal standard. The enantioseparation of cloperastine was performed on a Chiralpak IA column with a mobile phase composed of acetonitrile‐water‐ammonium hydroxide (80:20:0.1, v/v/v) at a flow rate of 0.6 mL/min. Cloperastine enantiomers were detected by mass spectrometry in multiple reaction monitoring mode with a positive electrospray ionization source. The method was validated over the linear concentration range of 0.05 to 10.0 ng/mL (5.0 × 10−4 ng to 0.10 ng) for both enantiomers. The lower limit of quantification (LLOQ) for each analyte was determined as 0.05 ng/mL. The relative standard deviations (RSDs) of intraday and interday precision was less than 13.9%, and the relative error (RE) of accuracy ranged from −5.4% to 6.1%, which were within the acceptance criteria. Finally, an application to the stereoselective pharmacokinetics of cloperastine in rats was successfully realized in our assay. The developed method on a commercially available Chiralpak IA column under isocratic mobile phase is advantageous to analyze cloperastine enantiomers in plasma samples collected for enantioselective metabolism or drug interaction studies.


  • Hydroxypropyl β-cyclodextrin nanohybrid monoliths for use in capillary electrochromatography with UV detection: application to the enantiomeric separation of adrenergic drugs, anticholinergic drugs, antidepressants, azoles, and antihistamine

    by Li Zhou, Liangzhao Cai, Jia Lun, Min Zhao, Xingjie Guo

    Two kinds of hydroxypropyl β-cyclodextrin nanohybrid monoliths were synthesized and applied in capillary electrochromatography with UV detection. One column was fabricated by concurrently using glycidyl methacrylate-bonded hydroxypropyl β-cyclodextrin (GMA-HP-β-CD), sodium 3-mercaptopropanesulphonate, and alkoxysilanes in the “one-pot” process. The other was prepared by free radical polymerization of GMA-HP-β-CD, vinylmethylcyclosiloxane, ethylene dimethacrylate, and 2-acrylamido-2-methyl propane sulfonic acid. Compared to the former hybrid monolith, the latter one displayed improved enantiomeric separation. For ten adrenergic drugs, six anticholinergic drugs, two antidepressants, six azoles, and one antihistamine enantiomeric separation was obtained on the monolith synthesized by free radical polymerization. Twelve out of twenty-five drugs were baseline-separated. Especially, anisodamine with two chiral centers was successfully separated with resolution values of 3.06, 2.11, and 2.17. The nanohybrid monoliths were characterized by optical microscopy, scanning electron microscopy, FT-IR, nitrogen adsorption analysis, and thermogravimetric analysis. Relative standard deviation values less than 5% were obtained through run-to-run, day-to-day, and column-to-column investigations (n = 3). Schematic representation of two kinds of hydroxypropyl β-cyclodextrin nanohybrid monoliths based on “one-pot” approach (route I) and free radical polymerization approach (route II), respectively.